Does RIBOCICLIB Cause Type 2 diabetes mellitus? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Type 2 diabetes mellitus have been filed in association with RIBOCICLIB (KISQALI). This represents 0.2% of all adverse event reports for RIBOCICLIB.
42
Reports of Type 2 diabetes mellitus with RIBOCICLIB
0.2%
of all RIBOCICLIB reports
6
Deaths
19
Hospitalizations
How Dangerous Is Type 2 diabetes mellitus From RIBOCICLIB?
Of the 42 reports, 6 (14.3%) resulted in death, 19 (45.2%) required hospitalization, and 2 (4.8%) were considered life-threatening.
Is Type 2 diabetes mellitus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Type 2 diabetes mellitus?
ATORVASTATIN (7,556)
ADALIMUMAB (3,516)
PREDNISONE (3,484)
METHOTREXATE (3,465)
RITUXIMAB (3,318)
TOCILIZUMAB (3,145)
ABATACEPT (3,074)
LEFLUNOMIDE (3,033)
ALENDRONATE (3,002)
DICLOFENAC (2,974)
Which RIBOCICLIB Alternatives Have Lower Type 2 diabetes mellitus Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN